Ding et al. [20] provides the initial clinical evidence showing that female COVID-19 patients probably have an ovarian injury of poor ovarian reserve and reproductive endocrine disorder with decreased AMH and aberrant sex hormone levels, especially high T and PRL. This evidence concerns the gene AMH and COVID-19.